Pharmacological inhibition of CD28-stimulated T cell activation
- 1 August 1995
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 44 (2) , S203-S204
- https://doi.org/10.1007/bf01778334
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.Proceedings of the National Academy of Sciences, 1994
- Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cellsInflammation Research, 1993
- CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clonesNature, 1992
- Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation.The Journal of Immunology, 1990
- T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.Proceedings of the National Academy of Sciences, 1990
- Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.The Journal of Immunology, 1990